|
1
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stupp R, Taillibert S, Kanner A, Read W,
Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K,
et al: Effect of tumor-treating fields plus maintenance
temozolomide vs maintenance temozolomide alone on survival in
patients with glioblastoma: A randomized clinical trial. JAMA.
318:2306–2316. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bensaad K, Tsuruta A, Selak MA, Vidal MN,
Nakano K, Bartrons R, Gottlieb E and Vousden KH: TIGAR, a
p53-inducible regulator of glycolysis and apoptosis. Cell.
126:107–120. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Green DR and Chipuk JE: P53 and
metabolism: Inside the TIGAR. Cell. 126:30–32. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Agnoletto C, Melloni E, Casciano F,
Rigolin GM, Rimondi E, Celeghini C, Brunelli L, Cuneo A, Secchiero
P and Zauli G: Sodium dichloroacetate exhibits anti-leukemic
activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes
with the p53 activator Nutlin-3. Oncotarget. 5:4347–4360. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou X, Xie W, Li Q, Zhang Y, Zhang J,
Zhao X, Liu J and Huang G: TIGAR is correlated with maximal
standardized uptake value on FDG-PET and survival in non-small cell
lung cancer. PLoS One. 8:e805762013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ko YH, Domingo-Vidal M, Roche M, Lin Z,
Whitaker-Menezes D, Seifert E, Capparelli C, Tuluc M, Birbe RC,
Tassone P, et al: TIGAR metabolically reprograms carcinoma and
stromal cells in breast cancer. J Biol Chem. 116:7402092016.
|
|
8
|
Zou S, Gu Z, Ni P, Liu X, Wang J and Fan
Q: SP1 plays a pivotal role for basal activity of TIGAR promoter in
liver cancer cell lines. Mol Cell Biochem. 359:17–23. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheung EC, Athineos D, Lee P, Ridgway RA,
Lambie W, Nixon C, Strathdee D, Blyth K, Sansom OJ and Vousden KH:
TIGAR is required for efficient intestinal regeneration and
tumorigenesis. Dev Cell. 25:463–477. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee P, Vousden KH and Cheung EC: TIGAR,
TIGAR, burning bright. Cancer Metab. 2:12014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mizuno H, Kitada K, Nakai K and Sarai A:
PrognoScan: A new database for meta-analysis of the prognostic
value of genes. BMC Med Genomics. 2:182009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Griffith OW: Determination of glutathione
and glutathione disulfide using glutathione reductase and
2-vinylpyridine. Anal Biochem. 106:207–212. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nielsen F, Mikkelsen BB, Nielsen JB,
Andersen HR and Grandjean P: Plasma malondialdehyde as biomarker
for oxidative stress: Reference interval and effects of life-style
factors. Clin Chem. 43:1209–1214. 1997.PubMed/NCBI
|
|
14
|
Xie JM, Li B, Yu HP, Gao QG, Li W, Wu HR
and Qin ZH: TIGAR has a dual role in cancer cell survival through
regulating apoptosis and autophagy. Cancer Res. 74:5127–5138. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee SY: Temozolomide resistance in
glioblastoma multiforme. Genes Dis. 3:198–210. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeng WF, Navaratne K, Prayson RA and Weil
RJ: Aurora B expression correlates with aggressive behaviour in
glioblastoma multiforme. J Clin Pathol. 60:218–221. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Heerboth S, Housman G, Leary M, Longacre
M, Byler S, Lapinska K, Willbanks A and Sarkar S: EMT and tumor
metastasis. Clin Transl Med. 4:62015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li X, Wu C, Chen N, Gu H, Yen A, Cao L,
Wang E and Wang L: PI3K/Akt/mTOR signaling pathway and targeted
therapy for glioblastoma. Oncotarget. 7:33440–33450.
2016.PubMed/NCBI
|
|
19
|
Agarwal E, Brattain MG and Chowdhury S:
Cell survival and metastasis regulation by Akt signaling in
colorectal cancer. Cell Signal. 25:1711–1719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gladson CL, Prayson RA and Liu WM: The
pathobiology of glioma tumors. Annu Rev Pathol. 5:33–50. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Delgado-Lopez PD and Corrales-Garcia EM:
Survival in glioblastoma: A review on the impact of treatment
modalities. Clin Transl Oncol. 18:1062–1071. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xie Q, Mittal S and Berens ME: Targeting
adaptive glioblastoma: An overview of proliferation and invasion.
Neuro Oncol. 16:1575–1584. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen X, Zhang M, Gan H, Wang H, Lee JH,
Fang D, Kitange GJ, He L, Hu Z, Parney IF, et al: A novel enhancer
regulates MGMT expression and promotes temozolomide resistance in
glioblastoma. Nat Commun. 9:29492018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Blagosklonny MV: Loss of function and p53
protein stabilization. Oncogene. 15:1889–1893. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fischer M: Census and evaluation of p53
target genes. Oncogene. 36:3943–3956. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang WB, Wang Z, Shu F, Jin YH, Liu HY,
Wang QJ and Yang Y: Activation of AMP-activated protein kinase by
temozolomide contributes to apoptosis in glioblastoma cells via p53
activation and mTORC1 inhibition. J Biol Chem. 285:40461–40471.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee P, Hock A, Vousden K and Cheung E:
P53-and p73-independent activation of TIGAR expression in
vivo. Cell Death Dis. 6:e18422015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheung EC, Ludwig RL and Vousden KH:
Mitochondrial localization of TIGAR under hypoxia stimulates HK2
and lowers ROS and cell death. Proc Natl Acad Sci USA.
109:20491–20496. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Y, Chen F, Tai G, Wang J, Shang J,
Zhang B, Wang P, Huang B, Du J, Yu J, et al: TIGAR knockdown
radiosensitizes TrxR1-overexpressing glioma in vitro and
in vivo via inhibiting Trx1 nuclear transport. Sci Rep.
7:429282017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang H, Gu C, Yu J, Wang Z, Yuan X, Yang
L, Wang J, Jia Y, Liu J and Liu F: Radiosensitization of glioma
cells by TP53-induced glycolysis and apoptosis regulator knockdown
is dependent on thioredoxin-1 nuclear translocation. Free Radic
Biol Med. 69:239–248. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu HP, Xie JM, Li B, Sun YH, Gao QG, Ding
ZH, Wu HR and Qin ZH: TIGAR regulates DNA damage and repair through
pentosephosphate pathway and Cdk5-ATM pathway. Sci Rep. 5:98532015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li M, Sun M, Cao L, Gu JH, Ge J, Chen J,
Han R, Qin YY, Zhou ZP, Ding Y and Qin ZH: A TIGAR-regulated
metabolic pathway is critical for protection of brain ischemia. J
Neurosci. 34:7458–7471. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Oda K, Stokoe D, Taketani Y and McCormick
F: High frequency of coexistent mutations of PIK3CA and PTEN genes
in endometrial carcinoma. Cancer Res. 65:10669–10673. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Luo J, Manning BD and Cantley LC:
Targeting the PI3K-Akt pathway in human cancer: Rationale and
promise. Cancer Cell. 4:257–262. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vanhaesebroeck B, Guillermet-Guibert J,
Graupera M and Bilanges B: The emerging mechanisms of
isoform-specific PI3K signalling. Nat Rev Mol Cell Biol.
11:329–341. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao L and Vogt PK: Class I PI3K in
oncogenic cellular transformation. Oncogene. 27:5486–5496. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ebner M, Sinkovics B, Szczygiel M, Ribeiro
DW and Yudushkin I: Localization of mTORC2 activity inside cells. J
Cell Biol. 216:343–353. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fan QW and Weiss WA: Autophagy and Akt
promote survival in glioma. Autophagy. 7:536–538. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rajasekhar VK, Viale A, Socci ND, Wiedmann
M, Hu X and Holland EC: Oncogenic Ras and Akt signaling contribute
to glioblastoma formation by differential recruitment of existing
mRNAs to polysomes. Mol Cell. 12:889–901. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gao T, Furnari F and Newton AC: PHLPP: A
phosphatase that directly dephosphorylates Akt, promotes apoptosis,
and suppresses tumor growth. Mol Cell. 18:13–24. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Assad Kahn S, Costa SL, Gholamin S, Nitta
RT, Dubois LG, Fève M, Zeniou M, Coelho PL, El-Habr E, Cadusseau J,
et al: The anti-hypertensive drug prazosin inhibits glioblastoma
growth via the PKCdelta-dependent inhibition of the AKT pathway.
EMBO Mol Med. 8:511–526. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dasgupta S, Rajapakshe K, Zhu B, Nikolai
BC, Yi P, Putluri N, Choi JM, Jung SY, Coarfa C, Westbrook TF, et
al: Metabolic enzyme PFKFB4 activates transcriptional coactivator
SRC-3 to drive breast cancer. Nature. 556:249–254. 2018. View Article : Google Scholar : PubMed/NCBI
|
